Antibody–Drug Conjugates and Small Molecule–Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents-Reference-Cited by-同舟云学术

Antibody–Drug Conjugates and Small Molecule–Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents

Published:2015-07-23 Issue:22 Volume:58 Page:8751-8761
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Casi Giulio¹,Neri Dario²

Affiliation:

1. Philochem AG, Libernstrasse 3, CH8112 Otelfingen, Switzerland

2. Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, Vladimir-Prelog-Weg 1-5/10, 8093 Zürich, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00457

Reference112 articles.

1. Testicular Cancer — Discoveries and Updates

2. Targeting multidrug resistance in cancer

3. Small Targeted Cytotoxics: Current State and Promises from DNA-Encoded Chemical Libraries

4. Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance study of the association between peripheral neuropathy and antibody–drug conjugates using the FDA adverse event reporting system;Scientific Reports;2024-09-13

2. Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models;Biomaterials;2024-09

3. Simultaneous Protein Adsorption and Viscosity Measurement using Micropillar-Enhanced Acoustic Wave (μPAW) Device for Pharmaceutical Applications;Journal of Pharmaceutical Sciences;2024-09

4. A novel HER2 targeting nanoagent self-assembled from affibody-epothilone B conjugate for cancer therapy;Journal of Nanobiotechnology;2024-08-21

5. Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities;Pharmaceutical Science Advances;2024-08